Baxter International (WBO:BAX) Beta: 1.0848 (As of Jun. 25, 2026)


WBO:BAX Baxter International Inc WBO:BAX
56 GF Score
Price €18.38
GF Value €28.97
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Baxter International Beta?

Baxter International WBO:BAX +4.49% 56 Beta is 1.0848 as of Jun. 25, 2026. GuruFocus rates WBO:BAX with a GF Score™ of 56/100 and a GF Value™ of €28.97 (Possible Value Trap). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Baxter International's Beta is 1.0848.


Baxter International  (WBO:BAX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Baxter International Beta Related Terms


Baxter International Beta Historical Data

* Premium members only.

The historical data trend for Baxter International's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Beta Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.13 0.34 -0.23 -0.44

Baxter International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.24 0.35 -0.44 0.99

WBO:BAX vs COO, ATR, RGEN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Beta distribution charts can be found below:

* The bar in red indicates where Baxter International's Beta falls into.


WBO:BAX
56GF Score
Baxter International Inc WBO:BAX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.0848 mean?
Baxter International (WBO:BAX) has a Beta of 1.0848 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Baxter International and its competitors.
Is Baxter International's Beta too high?
Baxter International's current Beta is 1.0848. Overall, Baxter International has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Beta compare to COO and ATR?
Baxter International's Beta of 1.0848 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Baxter International and its competitors. Baxter International's current Beta is 1.0848. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (WBO:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is €28.97, compared to a current price of €18.38 — trading 36.6% below its estimated fair value. The current Beta is 1.0848. Baxter International's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Baxter International (WBO:BAX), the current Beta is 1.0848 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (WBO:BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of €18.38 is trading 36.6% below its estimated GF Value™ of €28.97. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for WBO:BAX:

  • Beta: 1.0848
  • GF Value™: €28.97 vs. price of €18.38 (36.6% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the WBO:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
56GF Score

Get the complete analysis for WBO:BAX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.38
Price
€28.97
GF Value